APLS — APELLIS PHARMACEUTICALS INC

Ownership history in Kynam Capital Management, LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Kynam Capital Management, LP reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.38% (2022 Q4)
Avg. % of fund
1.73%
First filed
2022 Q4
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 908,607 +100,000 +12.4% 1.46% $22.8M $25.12
2025 Q3 ADDED 808,607 +508,607 +169.5% 1.36% $18.3M $22.63
2022 Q4 INITIATED 300,000 — — 2.38% $15.5M —
% of Fund (quarterly)    APLS price (monthly, adj. close)

Other funds also holding APLS

As of 2025 Q4 — sorted by position size

Deep Track Capital, LP 3Y 3.47% Avoro Capital Advisors LLC 3Y 7Y 3.02% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.13% Siren, L.L.C. 1.93% RTW INVESTMENTS, LP 3Y 7Y 1.93% Exome Asset Management LLC 1.63% Logos Global Management LP 3Y 1.52% ORBIMED ADVISORS LLC 3Y 7Y 1.25% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.22% HighVista Strategies LLC 3Y 7Y 0.98%
← Back to Kynam Capital Management, LP Holdings